XML 39 R27.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Dec. 31, 2019
Accounting Policies [Abstract]  
Restrictions on Cash and Cash Equivalents The following table provides a reconciliation of the total cash, cash equivalents and restricted cash reported on the Condensed Consolidated Balance Sheets to the corresponding amounts reported on the Condensed Consolidated Statements of Cash Flows.
 
 
Cash, Cash Equivalents and Restricted Cash
 
 
December 31, 2019
 
December 31, 2018
 
September 30, 2019
 
September 30, 2018
Cash and cash equivalents
 
$
333.4

 
$
477.6

 
$
447.1

 
$
452.6

Restricted cash
 
95.8

 
17.4

 
63.7

 
9.6

Cash, cash equivalents and restricted cash
 
$
429.2

 
$
495.0

 
$
510.8

 
$
462.2


Schedule of Cash and Cash Equivalents The following table provides a reconciliation of the total cash, cash equivalents and restricted cash reported on the Condensed Consolidated Balance Sheets to the corresponding amounts reported on the Condensed Consolidated Statements of Cash Flows.
 
 
Cash, Cash Equivalents and Restricted Cash
 
 
December 31, 2019
 
December 31, 2018
 
September 30, 2019
 
September 30, 2018
Cash and cash equivalents
 
$
333.4

 
$
477.6

 
$
447.1

 
$
452.6

Restricted cash
 
95.8

 
17.4

 
63.7

 
9.6

Cash, cash equivalents and restricted cash
 
$
429.2

 
$
495.0

 
$
510.8

 
$
462.2


Shares Used in Computing Basic and Diluted Earnings Per Share
Shares used in computing basic and diluted earnings per share are as follows: 
 
 
Three Months Ended
December 31,
 
 
2019
 
2018
Denominator (thousands of shares):
 
 
 
 
Weighted-average common shares outstanding — basic (a)
 
209,439

 
174,413

Incremental shares issuable for stock options and awards (b)
 
1,819

 
3,153

Weighted-average common shares outstanding — diluted
 
211,258

 
177,566


(a)
The three months ended December 31, 2019, reflects the August 2019 issuance of 34,613 shares of UGI Common Stock in connection with the AmeriGas Merger.
(b)
For the three months ended December 31, 2019 and 2018, there were 3,499 and 30 shares, respectively, associated with outstanding stock option awards that were excluded from the computation of diluted earnings per share above because their effect was antidilutive.